Nkgen Biotech, Inc.
NKGN
Revenue
0.00
▼-3.00k▼-100.00%
12 Months ChangeAssets
15.00M
▼-653.00k▼-4.17%
3 Months ChangeLiabilities
62.05M
▼-23.32M▼-27.32%
3 Months ChangeFree Cash Flow
-21.95M
▲710.00k▲3.13%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-30
Form 8-K
ID: 0001213900-24-092361
2024-10-24
Form 8-K
ID: 0001213900-24-090370
2024-10-10
Form 8-K
ID: 0001213900-24-086716
2024-10-04
Form 8-K
ID: 0001213900-24-085185
2024-10-03
Form 8-K
ID: 0001213900-24-085116
2024-09-27
Form 8-K
ID: 0001213900-24-082695
2024-09-20
Form 8-K
ID: 0001213900-24-080690
2024-09-17
Form 8-K
ID: 0001213900-24-079142
2024-09-16
Form 8-K
ID: 0001213900-24-078986
2024-09-12
Form 10-Q
ID: 0001628280-24-040255